Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
02/28/2002 | CA2420101A1 Kidney-specific protein |
02/28/2002 | CA2420087A1 Cripto tumour polypeptide |
02/28/2002 | CA2420071A1 Process for the preparation of neutrophil inhibitory factor |
02/28/2002 | CA2420054A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
02/28/2002 | CA2420051A1 Pharmaceutical composition comprising trkaig2 for use in the prevention and/or treatment of cancer |
02/28/2002 | CA2420036A1 Human 7tm proteins and polynucleotides encoding the same |
02/28/2002 | CA2419981A1 Coaster, a human coactivator of steroid receptors |
02/28/2002 | CA2419919A1 Novel imidazoline receptor homologs |
02/28/2002 | CA2419901A1 Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production |
02/28/2002 | CA2419810A1 Mfq-111, a novel human gtpase like protein |
02/28/2002 | CA2419454A1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
02/28/2002 | CA2419306A1 23 human secreted proteins |
02/28/2002 | CA2419029A1 Bacillus thuringiensis crystal protein hybrids |
02/28/2002 | CA2418680A1 11 human secreted proteins |
02/28/2002 | CA2418676A1 21 human secreted proteins |
02/28/2002 | CA2418474A1 21 human secreted proteins |
02/28/2002 | CA2418006A1 Binding polypeptides for b lymphocyte stimulator protein (blys) |
02/28/2002 | CA2417186A1 Microtubule-associated proteins and tubulins |
02/28/2002 | CA2388061A1 Diagnosis and treatment of cardiovascular conditions |
02/28/2002 | CA2356124A1 Anti-ige vaccines |
02/28/2002 | CA2355921A1 Isolated antioxidant peptides from casein and methods for preparing, isolating, and identifying antioxidant peptides |
02/27/2002 | EP1182257A1 Nucleic acids encoding dihydroflavonol 4-reductase with altered specificity and uses thereof |
02/27/2002 | EP1182256A1 Pollinosis-associated gene 513 |
02/27/2002 | EP1182255A1 Genes involved in immune related responses observed with asthma |
02/27/2002 | EP1182251A1 Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of IkB |
02/27/2002 | EP1182213A1 Hybrid enzyme and use thereof |
02/27/2002 | EP1182212A2 Ultraspiracle USP-protetin of Heliothis virescens |
02/27/2002 | EP1182211A1 Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity |
02/27/2002 | EP1182210A1 Epitopes of tumor-associated MUC1 antigen |
02/27/2002 | EP1182209A2 A method for extraction and purification of cartilage type proteoglycan |
02/27/2002 | EP1182208A2 Composition for DNA transfection |
02/27/2002 | EP1181555A1 Cancer treatment with endothelin receptor antagonists |
02/27/2002 | EP1181549A1 Protein-protein interactions |
02/27/2002 | EP1181393A2 CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L11/GTPASE ACTIVATING REGION rRNA AND USES THEREOF |
02/27/2002 | EP1181391A2 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents |
02/27/2002 | EP1181390A1 27 human secreted proteins |
02/27/2002 | EP1181385A2 Modulation of gene expression in gastrointestinal inflammation |
02/27/2002 | EP1181378A1 Fusion proteins comprising a fragment of a chaperon polypeptide |
02/27/2002 | EP1181377A2 Protein conjugates, methods, vectors, proteins and dna for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates |
02/27/2002 | EP1181376A2 Gene construct for prodrug activation encoding a heterologous, glycosylphophatidylinositol-modified carboxypeptidase g2 and a cell surface targeting signal peptide |
02/27/2002 | EP1181372A2 Viral expression vectors |
02/27/2002 | EP1181371A2 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
02/27/2002 | EP1181370A1 Methods and gene products for altering the shape of cells and organs in plants |
02/27/2002 | EP1181369A1 Four-helical bundle protein zsig81 |
02/27/2002 | EP1181368A1 Muteins of bilin-binding protein |
02/27/2002 | EP1181367A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
02/27/2002 | EP1181366A1 Mammalian receptor proteins; related reagents and methods |
02/27/2002 | EP1181365A1 PrP-LIKE GENE |
02/27/2002 | EP1181364A1 Lipid metabolism transcription factor |
02/27/2002 | EP1181363A1 Recombinant human mannan-binding lectin |
02/27/2002 | EP1181362A1 Methods and reagents for inhibiting angiogenesis |
02/27/2002 | EP1181360A1 Molecular switches |
02/27/2002 | EP1181359A1 Gene switches |
02/27/2002 | EP1181358A2 Methods and materials for generating sh3 domains with tailored binding properties |
02/27/2002 | EP1181357A2 Molecules for disease detection and treatment |
02/27/2002 | EP1181353A1 Inducible packaging cell lines for lentivirus vectors |
02/27/2002 | EP1181351A1 Method of purifying heterologous proteins |
02/27/2002 | EP1181320A2 Somatic transgene immunization and related methods |
02/27/2002 | EP1181317A1 An integrin heterodimer and an alpha subunit thereof |
02/27/2002 | EP1181316A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
02/27/2002 | EP1181315A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
02/27/2002 | EP1181314A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations |
02/27/2002 | EP1181313A2 Peptides for vaccinating against human cmv |
02/27/2002 | EP1181312A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
02/27/2002 | EP1181306A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
02/27/2002 | EP1181303A1 50 human secreted proteins |
02/27/2002 | EP1181056A1 Lim mineralization protein splice variants |
02/27/2002 | EP1181052A1 Protein a based binding domains with desirable activities |
02/27/2002 | EP1181044A2 IMMOBILIZED LACTOFERRIN ( i Im /i -LF) ANTIMICROBIAL AGENTS AND USES THEREOF |
02/27/2002 | EP1181039A2 Therapeutic uses of bpi protein products in humans with otitis media with effusion |
02/27/2002 | EP1181038A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
02/27/2002 | EP1181037A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
02/27/2002 | EP1181031A1 Novel antiangiogenic peptides |
02/27/2002 | EP1180999A2 Recombinant vaccine against botulinum neurotoxin |
02/27/2002 | EP1180938A2 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
02/27/2002 | EP0842193B1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
02/27/2002 | EP0836380B1 Fgf9 as a specific ligand for fgfr3 |
02/27/2002 | EP0812200B1 Protein purification |
02/27/2002 | EP0800862B1 Adsorbent for endotoxin, tumor necrosis factor-alpha or interleukins, method for removal via adsorption, and adsorber |
02/27/2002 | EP0733114B1 Construction of pasteurella haemolytica mutants |
02/27/2002 | EP0598029B1 Retroviral vectors containing internal ribosome entry sites |
02/27/2002 | CN1338053A Diagnosis of demylelinating or spongiform disease |
02/27/2002 | CN1337883A Tumor necrosis factor antagonists and their use in endometriosis |
02/27/2002 | CN1337465A Gene sequency of specific dihydro-flavonol4-reducing enayme as code substrate and its use thereof |
02/27/2002 | CN1337406A Gel chromatographic process of extracting recombinant human epidermal growth factor from fermented liquid |
02/27/2002 | CN1337405A Sodium-ion drived chlorine-ion/exchange protein bicarbonate |
02/27/2002 | CN1337404A Short-chain nervous cobratoxin and its prepn and use |
02/27/2002 | CN1079833C Recombinant P53 adenovirus method and compositions |
02/27/2002 | CN1079832C Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell |
02/27/2002 | CN1079830C Methods and materials for treatment of individuals infected with intracellular infections agents |
02/27/2002 | CN1079679C Cascade polymer complexes, its preparation process and medicine containing said complexes |
02/26/2002 | US6350935 Fruit-specific and ripening-regulation expansin gene to control fruit texture and softening |
02/26/2002 | US6350933 RG polynucleotides for conferring powdery mildew resistance in plants |
02/26/2002 | US6350932 Evaluating therapy for modulating hair growth using a transgeneic rodent having mutant alleles genes of a vitamin d receptor gene; the rodent exhibits hair loss and lacks vitamin d receptor activity; determining therapy effects |
02/26/2002 | US6350867 Compositions and methods for enhancing osseous growth, repair and regeneration |
02/26/2002 | US6350866 A nucleic acid encoding a protein; for developing and screening drugs that bind and inhibit the protein; therapy for respiratory diseases |
02/26/2002 | US6350859 Class BI and CI scavenger receptors |
02/26/2002 | US6350858 A polypeptide involved in controlling phosphate retention; diagnosis and therapy for chronic kidney failure, end stage kidney disease, uremic bone disease, and cancer |
02/26/2002 | US6350857 Fifty-four homologue (ffh) from streptococcus pneumoniae |
02/26/2002 | US6350856 Cytokine suppressive anti-inflammatory drug binding protein |